Genomic classifier tests play heterogeneous role in prostate cancer risk classification
For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or treatment decisions, according to a review published in the Annals of Internal ...
Jan 21, 2025
0
13